Borgeson Blake sold RXRX
January 6, 2026 · Form 4 insider transaction
Borgeson Blake sold 220,000 shares of Recursion Pharmaceuticals, Inc. at $4.36 per share, a transaction worth $959.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
220,000
Price
$4.36
Total value
$959.2K
InsiderBorgeson Blake
Role—
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 6, 2026
Filing dateJanuary 8, 2026
Shares owned after6,649,863
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025.